08 / July / 2026 Brazil a potential global leader in cell and gene therapies, says Martin Bonamino INCA researcher discusses the challenges of using CAR-T cells, how access could be expanded through Brazil’s public health system (SUS), and the potential of gene editing to transform medicine By Moura Leite Netto
06 / July / 2026 In vivo CAR-T: therapy produces anti-cancer cells in the body Experimental approach uses viral vectors and nanoparticles to reprogram immune cells directly within the body, eliminating the need to manufacture cells in a lab By Rodrigo de Oliveira Andrade
20 / December / 2024 Postdoctoral fellowship in immuno-oncology Fellowship at the Immuno-oncology Research Center in São Paulo open to Brazilians and foreigners; applications accepted until 12/31 By Editorial staff
16 / April / 2024 Immunotherapy using checkpoint inhibitors brings new hope to many cancer patients, but there is a need for improvement Research focuses on understanding immune mechanisms behind anti-tumor immune responses in oncology patient volunteers By Kenneth J. Gollob*
19 / July / 2023 The reaction to immunotherapy Lidia Arantes from Hospital de Amor studies different responses to the treatment of patients with lung cancer By Ricardo Muniz
